Duchenne Muscular Dystrophy and Related Dystrophinopathies: Drug Development

By QPS / June 3, 2023

Post navigation

← Previous Guidance Document

Next Guidance Document →

Time is of the essence in Drug Development.

Contact the QPS Business Development Team Today!

Your link to a rewarding career.

Join the QPS team and be part of our growing organization.

Submit Your Resume

About qps

Mission, Vision, and Values
QPS History
Bioanalysis Milestones
Gene Therapy Milestones
Locations
Meet Our People
Blog
Careers
Agency Approved Drugs
QPS Privacy Policy

Mission, Vision, and Values
QPS History
Bioanalysis Milestones
Gene Therapy Milestones
Locations
Meet Our People
Blog
Careers
Agency Approved Drugs
QPS Privacy Policy

Preclinical Services

Assay Finder
DMPK
IND Package
Pharmacology
Toxicology

Assay Finder
DMPK
IND Package
Pharmacology
Toxicology

Clinical Services

Clinical Operations
Early Phase
Late Phase
Leukopak Services
Global Medical Affairs
Global Regulatory Affairs
Therapeutic Areas

Clinical Operations
Early Phase
Late Phase
Leukopak Services
Global Medical Affairs
Global Regulatory Affairs
Therapeutic Areas

Resources

Brochures
Case Studies
Conferences
eBooks
Guidance Documents
Milestones
Scientific Posters
Scientific Reference Articles
Thought Leadership
Videos/Webinars
White Papers

Brochures
Case Studies
Conferences
eBooks
Guidance Documents
Milestones
Scientific Posters
Scientific Reference Articles
Thought Leadership
Videos/Webinars
White Papers

Headquarters Location

Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711

+1 512 350 2827
+1 302 369 5602
[email protected]

Connect with us

Linkedin-in Youtube Facebook-f Instagram

Subscribe To Our Blog

"*" indicates required fields

Name

First Last

Email*

Address

State / Province / Region Country

Confirmation*

By submitting this form, you are consenting to receive marketing emails from QPS Holdings, LLC, Three Innovation Way, Suite 240, Newark, DE, 19711, US, http://www.qps.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe^® link, found at the bottom of every email. Emails are serviced by Constant Contact.